Quest Diagnostics Guides FY23 Adj. EPS In Line With Estimates - Update

RTTNews | 635 dagar sedan
Quest Diagnostics Guides FY23 Adj. EPS In Line With Estimates - Update

(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Quest Diagnostics Inc. (DGX) initiated its earnings, adjusted earnings and revenue guidance for the full-year 2023.

For fiscal 2023, the company now projects earnings in a range of $7.61 and $8.21 per share and adjusted earnings in a range of $8.40 and $9.00 per share on net revenues between $8.83 billion and $9.03 billion.

On average, 16 analysts polled by Thomson Reuters expect the company to report earnings of $8.69 per share on revenues of $9.13 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
Quest Diagnostics To Acquire Outreach Laboratory Services Of OhioHealth

Quest Diagnostics To Acquire Outreach Laboratory Services Of OhioHealth

Quest Diagnostics (DGX), a provider of diagnostic information services, and OhioHealth, a nationally recognized not-for-profit, charitable, integrated health system, announced Wednesday a definitive agreement for Quest to acquire select assets of OhioHealth's outreach laboratory services business.
RTTNews | 111 dagar sedan
Quest Diagnostics To Acquire LifeLabs From OMERS In About $985 Mln Deal

Quest Diagnostics To Acquire LifeLabs From OMERS In About $985 Mln Deal

Quest Diagnostics (DGX), a provider of diagnostic information services, announced Wednesday a definitive agreement to acquire LifeLabs, a provider of community laboratory tests for millions of Canadians, from OMERS for a value of approximately C$1.35 billion (approximately $985 million), including net debt.
RTTNews | 118 dagar sedan